Dieng M-T, Sy M-H, Diop B-M, Niang S-O, Ndiaye B
Service de Dermatologie, CHU Le Dantec, Dakar, Sénégal.
Ann Dermatol Venereol. 2003 Jan;130(1 Pt 1):16-9.
Mycetoma is a pathological process in which eumycotic (fungal) or actinomycotic causative agents from exogenous source produce grains. It follows penetrating injury inoculating soil organisms, occurring preferentially in rural areas usually among labourers who work barefoot. Mycetoma is a localized chronic, and deforming infectious disease of subcutaneous tissues, skin and bones. We report 130 cases of mycetoma in Senegal from 1983 to 2000.
There were 130 patients with mycetoma. Clinical diagnosis of mycetoma was based on open tract sinuses, tumefaction or discharge of grain. Diagnosis confirmation was based on mycology and histology. An X-ray was preformed to detect bone lesions. Treatment was medical for actinomycetoma and surgical for eumycetoma.
We observed 76 actinomycetoma and 54 eumycetoma (Sex ratio M/F=6.6; mean age=34.7 +/- 14.8 years). The mean duration before the first medical evaluation was 4.8 +/- 5.6 years. Actinomycetoma was due to Actinomadura pelletieri, (54 cases), Actinomadura madurae (17 cases) and Streptomyces somaliensis (5 cases). Eumycetoma was due to Madurella mycetomatis (38 cases), Leptospahria senegalensis (9 cases), Pseudoallescheria boydii (6 cases) and Rhinoclediella atrovirens (1 case). Clinical inflammatory features significantly associated with actinomyces (p<0.001 OR=2.64) were predominant (85 cases). Tumoral and cystic features were found in the others forms. Lesions were located on the foot in 81 patients. Bone lesions, depending on the duration, were observed in 68 patients. Neurological damage occurred in 3 patients with dorsolumbar actinomycetoma. Sixty-six patients with actinomycetoma were cured by medical treatment.
The 130 cases of mycetoma were remarkable by the long duration of the disease before the first medical evaluation. Pain and tumor were the two main symptoms which brought the patients to the hospital and had appeared after 5 years duration and the predominance of actinomadura pelletieri actinomycetoma was responsible for 41.3 p. 100 of our cases. In Niger and Mauritania, mycetoma were actinomycetoma in respectively 71.2 p. 100 and 25 p. 100 of cases. The geographic distribution of pathogenic mycetoma agents was determined by the annual rainfall. Distinction between eumycetoma and actinomycetoma is very important for the treatment.
足菌肿是一种病理过程,外源性真菌或放线菌病原体在其中产生颗粒。它继发于接种土壤微生物的穿透性损伤,多见于农村地区,通常发生在赤足劳作的劳动者中。足菌肿是一种皮下组织、皮肤和骨骼的局限性慢性变形性传染病。我们报告了1983年至2000年塞内加尔的130例足菌肿病例。
130例足菌肿患者。足菌肿的临床诊断基于开放性窦道、肿胀或颗粒排出。诊断的确立基于真菌学和组织学检查。进行X线检查以检测骨病变。放线菌性足菌肿采用药物治疗,真菌性足菌肿采用手术治疗。
我们观察到76例放线菌性足菌肿和54例真菌性足菌肿(性别比M/F = 6.6;平均年龄 = 34.7±14.8岁)。首次就医前的平均病程为4.8±5.6年。放线菌性足菌肿由佩氏马杜拉放线菌(54例)、马杜拉马杜拉放线菌(17例)和索马里链霉菌(5例)引起。真菌性足菌肿由马杜拉真菌(38例)、塞内加尔细交链孢(9例)、博伊德假性阿利什霉(6例)和黑色鼻疽菌(1例)引起。与放线菌显著相关的临床炎症特征(p<0.001,OR = 2.64)占主导(85例)。其他类型则表现为肿瘤性和囊性特征。81例患者的病变位于足部。根据病程,68例患者观察到骨病变。3例背腰部放线菌性足菌肿患者出现神经损伤。66例放线菌性足菌肿患者经药物治疗治愈。
这130例足菌肿病例的显著特点是首次就医前病程较长。疼痛和肿块是导致患者就医的两个主要症状,在病程5年后出现,且佩氏马杜拉放线菌性足菌肿占我们病例的41.3%。在尼日尔和毛里塔尼亚,足菌肿分别占病例的71.2%和25%。致病性足菌肿病原体的地理分布由年降雨量决定。区分真菌性足菌肿和放线菌性足菌肿对治疗非常重要。